CIK 0001314102 · Non-accelerated filer<br>Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262774444
- Phone
- 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $52,258
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$52,258. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-30 | Paggiarino Dario A. Chief Medical Officer | Shares withheld for taxes | −15,493 | $20.67 | $320K | 77,133 |
| 2024-03-30 | Paggiarino Dario A. Chief Medical Officer | Shares withheld for taxes | −2,957 | $20.67 | $61K | 74,176 |
| 2024-03-30 | Paggiarino Dario A. Chief Medical Officer | Shares withheld for taxes | −7,096 | $20.67 | $147K | 67,080 |
| 2024-03-30 | Paggiarino Dario A. Chief Medical Officer | Option exercise · Restricted Stock Units | −30,570 | 0 | ||
| 2024-03-30 | Paggiarino Dario A. Chief Medical Officer | Option exercise · Restricted Stock Units | −5,834 | 0 | ||
| 2024-03-30 | Paggiarino Dario A. Chief Medical Officer | Option exercise · Restricted Stock Units | −14,000 | 0 | ||
| 2024-03-01 | Ribeiro Ramiro Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2024-02-27 | Duker Jay S. President and CEO | Gift | −2,500 | 29,420 | ||
| 2024-02-27 | Duker Jay S. President and CEO | Gift | +2,500 | 22,500 | ||
| 2024-02-20 | Duker Jay S. President and CEO | Gift | −20,000 | 31,920 | ||
| 2024-02-20 | Duker Jay S. President and CEO | Gift | +20,000 | 20,000 | ||
| 2024-02-13 | Lurker Nancy Executive Vice Chair | Gift | −74,681 | 83,351 | ||
| 2024-02-13 | Lurker Nancy Executive Vice Chair | Gift | +74,681 | 126,889 | ||
| 2024-02-13 | Lurker Nancy Executive Vice Chair | Gift · Stock Option (Right to Buy) | −3,116 | 1,558 | ||
| 2024-02-13 | Lurker Nancy Executive Vice Chair | Gift · Stock Option (Right to Buy) | +3,116 | 73,242 | ||
| 2024-02-13 | Lurker Nancy Executive Vice Chair | Gift · Stock Option (Right to Buy) | −4,452 | 57,878 | ||
| 2024-02-13 | Lurker Nancy Executive Vice Chair | Gift · Stock Option (Right to Buy) | +4,452 | 155,822 | ||
| 2024-02-13 | Lurker Nancy Executive Vice Chair | Gift · Stock Option (Right to Buy) | −5,000 | 125,000 | ||
| 2024-02-13 | Lurker Nancy Executive Vice Chair | Gift · Stock Option (Right to Buy) | +5,000 | 115,000 | ||
| 2024-02-09 | Lurker Nancy Executive Vice Chair | Option exercise | +20,000 | 155,441 |
Page 11 of 18 · 352 trades